MedPath

SUPRES 250 TAB

SUPRES 250 TAB

Discontinued
DIN Number

00231177

Drug Class

Human

Market Date

Dec 31, 1972

Company
HC

merck frosst canada & cie, merck frosst canada & co.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00231177
AIG Number0200051001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02LB01 METHYLDOPA (LEVOROTATORY) AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:08.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

CHLOROTHIAZIDEActive
Strength: 250 MG
Monograph: CHLOROTHIAZIDE
METHYLDOPAActive
Strength: 250 MG
Monograph: METHYLDOPA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.